您好,欢迎您

AACR2019癌症研究新视野大会设12个专题,齐聚众多国内外专家

2019年04月11日
来源:癌症研究全球资讯

1.jpg

期待已久的第五届AACR癌症研究新视野大会即将于5月3日-4日在深圳召开!本届会议将呈现吸引广大受众(例如基因组学,免疫疗法,药物开发等)的议题,以及针对该地区高发病灶部位(例如肺癌,鼻咽癌,肝癌等)的相关议题。

本届大会包含主旨演讲,2场全体大会,12场重点同期分论坛,2场海报分论坛以及3场卫星研讨会。

已确认演讲嘉宾:

Day 1

Keynote Speaker

  • Dongxin Lin, Chinese Academy of Medical Sciences, Beijing, China

Day 2

Speakers

Plenary Session 1: Genomics

  • Zemin Zhang, Peking University, Beijing, China

  • Timothy A. Chan, Memorial Sloan Kettering Cancer Center, New York, NY, USA

  • Suet Yi Leung, The University of Hong Kong, Hong Kong

  • Mao Mao, SeekIn, Inc., Shenzhen, China

  • Ke Liu, U.S. Food and Drug Administration, Silver Spring, MD, USA

  • Zengjun Xu, Center for Drug Evaluation, National Medical Products Administration, Beijing, China

Concurrent Session 1: Cancer Epigenetics

  • Qunying Lei, Fudan University, Shanghai, China

  • Gonghong Wei, University of Oulu, Oulu, Finland

  • Nilofer S. Azad, Johns Hopkins Sidney Kimmel Cancer Center, Baltimore, MD, USA

Concurrent Session 2: Lung Cancer

  • Bo Zhu, Institute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing, China

  • Hongbin Ji, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of  Sciences, Shanghai, China

  • Bruce Robinson, The University of Western Australia, Perth, Australia

  • Concurrent Session 3: Cancer Metabolism

  • Tak W. Mak, Campbell Family Institute for Breast Cancer Research, University of Toronto Health Network, Toronto, ON, Canada

  • Nobu-hiro Tanuma, Miyagi Cancer Center Research Institute, Natori, Japan

  • Shengcai Lin, Xiamen University School of Life Sciences, Xiamen, China

Concurrent Session 4: Leukemia and Lymphoma

  • Xiaojun Huang, Peking University, Beijing, China

  • James CS Chim, Queen Mary Hospital, University of Hong Kong, Hong Kong

  • Eduardo M. Sotomayor, George Washington University, Washington, DC, USA

Concurrent Session 5: New Drug Development

  • Ping Zhu, H3 Biomedicine, Cambridge, MA, USA

  • Melvin L.K. Chua, National Cancer Center Singapore, Singapore

  • Brigette B. Ma, Chinese University of Hong Kong, Hong Kong

Concurrent Session 6: Nasopharyngeal Carcinoma

  • Chao-Nan Qian, Sun Yat-Sen University Cancer Center, Guangzhou, China

  • Mu-Sheng Zeng, Sun Yat-Sen University Cancer Center, Guangzong, China

  • Anthony T.C. Chan, Chinese University of Hong Kong, Hong Kong

Day 3

Speaker

Plenary Session 2: Immunotherapy

  • Shannon L. Maude, Children’s Hospital of Philadelphia, Philadelphia, PA, USA

  • Elizabeth M. Jaffee, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA

  • Patrick Hwu, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

  • Chen Dong, Tsinghua University, Beijing, China

Concurrent Session 7: Male specific cancers:New insights into advanced prostate cancer

  • Wei-Qiang Gao, Shanghai Jiao Tong University, Shanghai, China

  • Mark A. Rubin, University of Bern, Bern, Switzerland

  • Cory Abate-Shen, Columbia University Irving Comprehensive Cancer Center, New York, NY, USA

Concurrent Session 8: Female Specificcancers

  • Hui-KuanLin, Wake Forest University School of Medicine, Winston Salem, NC, USA

  • Erwei Song, Sun Yat-Sen University, Guangzhou, China

  • Mien-Chie Hung, China Medical University, Taichung, Taiwan

Concurrent Session 9: New Technologies

  • Fuchou Tang, Peking University, Beijing, China

  • Janis M. Taube, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Concurrent Session 10: Liver Cancer

  • Hongyang Wang, National Center for Liver Cancer, Shanghai, China

  • Lars Zender, University Hospital Tübingen, Tübingen, Germany

  • Tim F. Greten, National Cancer Institute, Bethesda, MD, USA

Concurrent Session 11: Cancer Prevention

  • You-lin Qiao, Academy of Chinese Medicine, Beijing, China

  • Zigang Dong, University of Minnesota Hormel Institute, Austin, MN, USA

  • Adriana Albini, IRCCS MultiMedica, Milan, Italy

Concurrent Session 12: GI Cancers

  • Jin Gu, Peking University, Beijing, China

  • Aida Habtezion, Stanford University School of Medicine, Palo Alto, CA, USA

联系我们

注册参会:

021-3279 8782

registration@aacr.asia

赞助咨询:

021-3279 8716

sponsor@aacr.asia

会议网站:

nhicr.aacr.asia

合作单位

美国癌症研究学会(AACR)成立于1907年,致力于全面、创新和高水准癌症研究的科学组织。其科研范围广,吸引了众多的研究者,是发布有关癌症成因、诊断、治疗和预防进展的组织。

请点击“下方链接”,进入会议官网。

http://nhicr.aacr.asia/

评论
2019年04月29日
摄足
哈尔滨医科大学附属肿瘤医院 | 肿瘤内科
学习